Ind-Swift [INDSWFTLAB] vs Sakar Healthcare [SAKAR] Detailed Stock Comparison
Ind-Swift
NSE
Loading...
Sakar Healthcare
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Ind-Swift wins in 10 metrics, Sakar Healthcare wins in 7 metrics, with 0 ties. Ind-Swift appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ind-Swift | Sakar Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2.77 | 39.73 | Ind-Swift |
| Price-to-Book Ratio | 0.56 | 2.72 | Ind-Swift |
| Debt-to-Equity Ratio | 3.48 | 30.26 | Ind-Swift |
| PEG Ratio | N/A | 0.43 | N/A |
| EV/EBITDA | -13.71 | 16.68 | Ind-Swift |
| Profit Margin (TTM) | 40.55% | 10.45% | Ind-Swift |
| Operating Margin (TTM) | -2.01% | 13.53% | Sakar Healthcare |
| EBITDA Margin (TTM) | N/A | 13.53% | N/A |
| Return on Equity | 21.35% | 6.13% | Ind-Swift |
| Return on Assets (TTM) | 17.41% | 4.21% | Ind-Swift |
| Free Cash Flow (TTM) | $-898.80M | $17.50M | Sakar Healthcare |
| 1-Year Return | -23.32% | 14.93% | Sakar Healthcare |
| Price-to-Sales Ratio (TTM) | 1.40 | 4.16 | Ind-Swift |
| Enterprise Value | $2.41B | $8.66B | Sakar Healthcare |
| EV/Revenue Ratio | 0.43 | 4.58 | Ind-Swift |
| Gross Profit Margin (TTM) | 41.64% | 45.10% | Sakar Healthcare |
| Revenue per Share (TTM) | $84 | $86 | Sakar Healthcare |
| Earnings per Share (Diluted) | $35.21 | $9.02 | Ind-Swift |
| Beta (Stock Volatility) | 0.44 | 0.01 | Sakar Healthcare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Ind-Swift vs Sakar Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ind-Swift | -0.13% | -6.05% | -0.54% | -13.21% | 7.24% | -11.48% |
| Sakar Healthcare | -1.19% | -0.27% | 10.35% | 4.31% | 56.23% | 21.62% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ind-Swift | -23.32% | 71.58% | 65.03% | 214.60% | -29.26% | -46.38% |
| Sakar Healthcare | 14.93% | 53.50% | 544.64% | 511.33% | 511.33% | 511.33% |
News Based Sentiment: Ind-Swift vs Sakar Healthcare
Ind-Swift
News based Sentiment: MIXED
September presented a complex picture for Ind-Swift Laboratories, with concerning financial results countered by strong shareholder confidence and increased institutional investment. The 'Strong Sell' rating and shareholding shifts add to the uncertainty, making it a pivotal month for the company's direction.
Sakar Healthcare
News based Sentiment: MIXED
September brought both positive developments – an international licensing agreement – and concerning signals, like share price volatility and a high valuation. While the company demonstrates growth, the mixed signals create uncertainty for investors, making this a moderately significant month.
Performance & Financial Health Analysis: Ind-Swift vs Sakar Healthcare
| Metric | INDSWFTLAB | SAKAR |
|---|---|---|
| Market Information | ||
| Market Cap | ₹8.21B | ₹8.09B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 35,346 | 20,689 |
| 90 Day Avg. Volume | 40,280 | 15,405 |
| Last Close | ₹97.24 | ₹362.45 |
| 52 Week Range | ₹68.72 - ₹134.40 | ₹210.10 - ₹380.80 |
| % from 52W High | -27.65% | -4.82% |
| All-Time High | ₹296.50 (Dec 20, 2004) | ₹479.00 (Jan 22, 2024) |
| % from All-Time High | -67.20% | -24.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 3.61% | 0.28% |
| Quarterly Earnings Growth | 8.38% | 0.94% |
| Financial Health | ||
| Profit Margin (TTM) | 0.41% | 0.10% |
| Operating Margin (TTM) | -0.02% | 0.14% |
| Return on Equity (TTM) | 0.21% | 0.06% |
| Debt to Equity (MRQ) | 3.48 | 30.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹173.94 | ₹131.81 |
| Cash per Share (MRQ) | ₹68.18 | ₹0.14 |
| Operating Cash Flow (TTM) | ₹-213,518,000 | ₹223.74M |
| Levered Free Cash Flow (TTM) | ₹2.50B | ₹175.02M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Ind-Swift vs Sakar Healthcare
| Metric | INDSWFTLAB | SAKAR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2.77 | 39.73 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | 0.43 |
| Price to Sales (TTM) | 1.40 | 4.16 |
| Price to Book (MRQ) | 0.56 | 2.72 |
| Market Capitalization | ||
| Market Capitalization | ₹8.21B | ₹8.09B |
| Enterprise Value | ₹2.41B | ₹8.66B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.43 | 4.58 |
| Enterprise to EBITDA | -13.71 | 16.68 |
| Risk & Other Metrics | ||
| Beta | 0.44 | 0.01 |
| Book Value per Share (MRQ) | ₹173.94 | ₹131.81 |
Financial Statements Comparison: Ind-Swift vs Sakar Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INDSWFTLAB | SAKAR |
|---|---|---|
| Revenue/Sales | ₹5.08B | ₹527.36M |
| Cost of Goods Sold | ₹2.96B | ₹289.52M |
| Gross Profit | ₹2.11B | ₹237.84M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-48.60M | ₹71.34M |
| EBITDA | ₹298.46M | ₹131.00M |
| Pre-Tax Income | ₹2.57B | ₹53.85M |
| Income Tax | ₹81.90M | ₹7.14M |
| Net Income (Profit) | ₹2.49B | ₹46.71M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INDSWFTLAB | SAKAR |
|---|---|---|
| Cash & Equivalents | ₹4.12B | ₹1.02M |
| Total Current Assets | ₹8.65B | ₹887.27M |
| Total Current Liabilities | ₹2.21B | ₹631.86M |
| Long-Term Debt | ₹259.35M | ₹535.94M |
| Total Shareholders Equity | ₹11.73B | ₹2.85B |
| Retained Earnings | ₹-1.38B | ₹980.38M |
| Property, Plant & Equipment | ₹270.23M | ₹449.59M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INDSWFTLAB | SAKAR |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INDSWFTLAB | SAKAR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 35,346 | 20,689 |
| Average Daily Volume (90 Day) | 40,280 | 15,405 |
| Shares Outstanding | 60.62M | 21.95M |
| Float Shares | 29.83M | 7.43M |
| % Held by Insiders | 0.70% | N/A |
| % Held by Institutions | 0.05% | N/A |
Dividend Analysis & Yield Comparison: Ind-Swift vs Sakar Healthcare
| Metric | INDSWFTLAB | SAKAR |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |